Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Ingresos
2,052,148
1,886,256
1,601,688
1,278,478
1,044,892
962,516
Crecimiento de los Ingresos (YoY)
14%
18%
25%
22%
9%
-2%
Costo de los ingresos
460,944
415,797
415,322
363,525
353,328
338,289
Utilidad bruta
1,591,204
1,470,459
1,186,366
914,953
691,564
624,227
Venta, General y Administración
805,873
731,200
636,997
471,221
358,309
333,079
Investigación y Desarrollo
473,098
435,965
365,169
341,570
260,228
227,353
Gastos de Operación
1,273,815
1,138,534
974,778
794,373
618,539
560,432
Otras Ingresos (Gastos) No Operativos
0
838
-1,347
-197
-1,233
4,537
Ingreso antes de impuestos
350,581
355,631
237,234
126,854
73,516
74,124
Gasto por Impuesto a la Renta
45,981
63,017
34,403
17,902
6,521
-1,526
Ingreso Neto
304,599
295,756
200,731
109,188
66,972
75,958
Crecimiento de la Utilidad Neta
24%
47%
84%
63%
-12%
-41%
Acciones en Circulación (Diluidas)
1,851.04
1,897.45
1,918.65
1,918.58
1,918.49
1,941.97
Cambio de Acciones (YoY)
-2%
-1%
0%
0%
-1%
0%
EPS (Diluido)
164.55
155.86
104.62
56.91
34.92
39.11
Crecimiento de EPS
27%
49%
84%
63%
-11%
-41%
Flujo de efectivo libre
-53,335
-134,030
467,245
47,148
62,544
128,114
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
77.53%
77.95%
74.06%
71.56%
66.18%
64.85%
Margen de operación
15.46%
17.59%
13.21%
9.43%
6.98%
6.62%
Margen de beneficio
14.84%
15.67%
12.53%
8.54%
6.4%
7.89%
Margen de flujo de caja libre
-2.59%
-7.1%
29.17%
3.68%
5.98%
13.31%
EBITDA
391,706
400,574
271,234
188,369
131,270
121,177
Margen de EBITDA
19.08%
21.23%
16.93%
14.73%
12.56%
12.58%
D&A para EBITDA
74,317
68,649
59,646
67,789
58,245
57,382
EBIT
317,389
331,925
211,588
120,580
73,025
63,795
Margen de EBIT
15.46%
17.59%
13.21%
9.43%
6.98%
6.62%
Tasa de Impuesto Efectiva
13.11%
17.71%
14.5%
14.11%
8.87%
-2.05%
Estadísticas clave
Cierre Anterior
$19.15
Precio de apertura
$19
Rango del día
$19 - $19
Rango de 52 semanas
$17.41 - $29.15
Volumen
200
Volumen promedio
62.9K
EPS (TTM)
0.94
Rendimiento de dividendos
--
Cap. de mercado
$35.1B
¿Qué es Daiichi Sankyo Co., Ltd.?
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 19,765 full-time employees. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.